Video

Dr. Lieberman previews the 2021 AACU annual meeting

Author(s):

Urology Times staff

Among the highlights will be a talk from Senator Bill Cassidy, MD (R-LA).

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, American Association of Clinical Urologists (AACU) President Elliott Lieberman, MD, outlines what members can expect from the 2021 AACU Annual Meeting, including presentations on malpractice, telemedicine, and more.

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      Subscribe Now!
      Related Videos
      Ruchika Talwar, MD, on how urologists can get involved in advocacy
      Ruchika Talwar, MD, on how urologists can get involved in advocacy
      Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment
      Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment
      Chad Ellimoottil, MD, highlights recent telehealth extension
      Chad Ellimoottil, MD, highlights recent telehealth extension
      Ruchika Talwar, MD, discusses ongoing drug shortages in urology
      Ruchika Talwar, MD, discusses ongoing drug shortages in urology
      Mark Edney, MD, highlights pending telehealth legislation
      Mark Edney, MD, highlights pending telehealth legislation
      Study highlights the importance of financial considerations for treatment decisions in urology
      Study highlights the importance of financial considerations for treatment decisions in urology
      Expert discusses advocacy for maintaining telemedicine reimbursement
      Expert discusses advocacy for maintaining telemedicine reimbursement
      Policy and practice implications of the Inflation Reduction Act for urology
      Policy and practice implications of the Inflation Reduction Act for urology
      Dr. Murphy highlights advocacy for PSA screening at the 2023 AUA Summit
      Dr. Murphy highlights advocacy for PSA screening at the 2023 AUA Summit
      Dr. Asafu-Adjei in an interview with Urology Times
      Dr. Asafu-Adjei on advancements she hopes to see come from the 2023 AUA Summit
      Related Content
      US Capitol building | Image Credit: © sherryvsmith - stock.adobe.com
      May 6th 2025

      AUA Advocacy Summit: Medicare payment reform among top priorities

      Jennifer Miles-Thomas, MD, URPS, MBA Benjamin P. Saylor
      Jennifer Miles-Thomas, MD, URPS, MBA, discusses the AUA's legislative priorities along with issues in medicine related to artificial intelligence.
      Lawmaker stands at podium | Image Credit: © ckybe - stock.adobe.com
      May 4th 2025

      Health policy expert highlights the importance of state-level urology advocacy

      Benjamin P. Saylor
      "Developing a relationship with your legislator is just as important at the state level as it is at the federal level," says Hans Arora, MD, PhD.
      Biomarkers in urology: Policy and legislative advances
      April 22nd 2025

      Biomarkers in urology: Policy and legislative advances

      Ron Lanton, Esq
      "The AACU has been discussing the evolution of state policy to ensure that biomarker testing, including PSA screening, is covered by payers," writes Ron Lanton, Esq.
      House passes bill that includes 57% budget cut to medical research programs
      March 12th 2025

      House passes bill that includes 57% budget cut to medical research programs

      Hannah Clarke
      This bill would cut funds for research projects in disease states such as prostate cancer, bladder cancer, kidney cancer, and interstitial cystitis.
      Data refute concerns about telehealth as Congress weighs legislation
      March 7th 2025

      Data refute concerns about telehealth as Congress weighs legislation

      Hannah Clarke
      “Five years after telehealth suddenly became a routine part of care for most Americans, we show that it has not led to runaway utilization or spending. This kind of in-depth analysis can inform its future," says Chad Ellimoottil, MD, MS.
      Enzalutamide included in next round of Medicare drug price negotiations
      January 17th 2025

      Enzalutamide included in next round of Medicare drug price negotiations

      Hannah Clarke
      The 15 drugs identified in this round of negotiations add to the 10 selected in the first round of negotiations that took place in 2023 and 2024.
      © 2025 MJH Life Sciences

      All rights reserved.